Personalized radioiodine therapy for thyroid cancer patients with known disease

xlomafota13 shared this article with you from Inoreader Personalized radioiodine therapy for thyroid cancer patients with known disease Via radioactive iodine Fac Rev. 2021 Apr 7;10:36. doi: 10.12703/r/10-36. eCollection 2021. ABSTRACT Radioactive iodine (RAI) 131I is a targeted therapy for patients with RAI-avid follicular cell-derived thyroid cancer. However, the responsiveness to 131I therapy varies among thyroid cancer patients mainly owing to differential RAI uptake and RAI radiosensitivity among patients' lesions. A personalized approach to maximize 131I therapeutic efficacy is proposed based on rec ent scientific advances and future opportunities. PMID:33977289 | PMC:PMC8103907 | DOI:10.12703/r/10-36 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.